Strategies to reduce drug-related harm: responding to the evidence base

Affiliations

¹ National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, NSW 2052, Australia. Electronic address: l.degenhardt@unsw.edu.au.
² International Harm Reduction Development, Public Health Program, Open Society Foundations, New York, NY, USA.
³ Centre for Youth Substance Abuse Research, The University of Queensland, Brisbane, QLD, Australia; National Addiction Centre, King's College London, London, UK.
⁴ Population Health Sciences, University of Bristol, Bristol, UK.
⁵ International Network of People Who Use Drugs, London, UK.
⁶ Research Center, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
⁷ National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, NSW 2052, Australia.
⁸ European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.

Comment

Louisa Degenhardt et al. Lancet. 2019.

. 2019 Oct 26;394(10208):1490-1493.

doi: 10.1016/S0140-6736(19)32232-9. Epub 2019 Oct 23.

¹ National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, NSW 2052, Australia. Electronic address: l.degenhardt@unsw.edu.au.
² International Harm Reduction Development, Public Health Program, Open Society Foundations, New York, NY, USA.
³ Centre for Youth Substance Abuse Research, The University of Queensland, Brisbane, QLD, Australia; National Addiction Centre, King's College London, London, UK.
⁴ Population Health Sciences, University of Bristol, Bristol, UK.
⁵ International Network of People Who Use Drugs, London, UK.
⁶ Research Center, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
⁷ National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, NSW 2052, Australia.
⁸ European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.

No abstract available

Comment on

The global drug problem: change but not progression.
Das P, Horton R. Das P, et al. Lancet. 2019 Oct 26;394(10208):1488-1490. doi: 10.1016/S0140-6736(19)32275-5. Epub 2019 Oct 23. Lancet. 2019. PMID: 31657726 No abstract available.